eli lilly glp-1 analog Ground News | Federal regulators approved Lilly's new weight-loss pill, orforglipron, giving patients a second daily oral treatment for obesity Eli Lilly stock pops after

Accordingly, various conceptualizations of food addiction reflect the DSM criteria for SUDs, emphasizing loss of control as a central element (Volkow and Wise, 2005

If GLP-1s are going to move from metabolic medicine into the worlds of pain and substance use disorders, we should talk about them the way we would talk about any powerful new class: with evidence, not mythology

And the honest answer is: what you eat on GLP-1 therapy matters more than most people realize

This commenter further noted that the substantial clinical improvement criterion should be applied rigorously and that innovations should earn supplemental payment only if they offer a real patient-care advantage, not merely convenience

[DOI] [PMC free article] [PubMed] [Google Scholar] 74.Wang Q.H., Li Y., Dou D.Y., Wang R., Jiang T.T., Wang L., et al

Effect of L-carnitine on the pyruvate dehydrogenase complex and carnitine palmitoyl transferase activities in muscle of endurance athletes